Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Paul Bunn

Concepts (1215)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
343
2024
2353
20.420
Why?
Carcinoma, Non-Small-Cell Lung
171
2024
1060
15.800
Why?
ErbB Receptors
69
2024
601
6.640
Why?
Antineoplastic Agents
103
2023
2038
6.090
Why?
Antineoplastic Combined Chemotherapy Protocols
95
2024
1570
5.730
Why?
Carcinoma, Small Cell
105
2008
170
5.100
Why?
Small Cell Lung Carcinoma
14
2024
82
4.680
Why?
Quinazolines
38
2016
245
4.580
Why?
Protein Kinase Inhibitors
32
2023
870
3.260
Why?
Paclitaxel
31
2011
214
2.640
Why?
Carboplatin
24
2019
140
2.320
Why?
Guanine
11
2007
79
2.130
Why?
Deoxycytidine
14
2004
163
2.040
Why?
Glutamates
11
2007
58
1.950
Why?
Molecular Targeted Therapy
13
2019
381
1.910
Why?
Neoplasm Staging
63
2018
1285
1.850
Why?
Adenocarcinoma
31
2017
895
1.770
Why?
Antibodies, Monoclonal
45
2018
1359
1.730
Why?
Biomarkers, Tumor
37
2021
1170
1.640
Why?
Humans
525
2024
128896
1.630
Why?
Neoadjuvant Therapy
9
2023
383
1.450
Why?
Antimetabolites, Antineoplastic
10
2007
90
1.450
Why?
Taxoids
13
2013
98
1.440
Why?
Receptor, ErbB-2
12
2019
333
1.430
Why?
Mutation
30
2024
3671
1.410
Why?
Skin Neoplasms
55
2010
828
1.370
Why?
Clinical Trials as Topic
51
2024
1002
1.360
Why?
Gene Expression Regulation, Neoplastic
24
2018
1312
1.330
Why?
Lymphoma
47
1991
190
1.280
Why?
Combined Modality Therapy
52
2023
1213
1.260
Why?
Antineoplastic Agents, Phytogenic
10
2007
189
1.240
Why?
Etoposide
26
2023
148
1.220
Why?
Cisplatin
31
2018
292
1.150
Why?
Survival Analysis
34
2019
1282
1.130
Why?
Vinblastine
8
2003
69
1.120
Why?
Carcinoma, Squamous Cell
21
2023
626
1.120
Why?
Sezary Syndrome
36
1996
43
1.090
Why?
Protein-Tyrosine Kinases
10
2023
421
1.090
Why?
Lymphoma, T-Cell, Cutaneous
9
2010
42
1.040
Why?
Drug Resistance, Neoplasm
19
2023
732
1.030
Why?
Mycosis Fungoides
38
1996
61
1.010
Why?
Antibodies, Monoclonal, Humanized
14
2023
750
1.010
Why?
Aged
142
2024
22035
0.990
Why?
Erlotinib Hydrochloride
12
2015
66
0.990
Why?
In Situ Hybridization, Fluorescence
22
2018
319
0.990
Why?
Precision Medicine
5
2024
385
0.960
Why?
Bradykinin
9
2005
46
0.960
Why?
Liposomes
3
2024
163
0.950
Why?
Pemetrexed
14
2024
34
0.940
Why?
Tumor Cells, Cultured
31
2014
928
0.900
Why?
Immunotherapy
13
2020
579
0.880
Why?
Middle Aged
169
2024
30977
0.880
Why?
Proto-Oncogene Proteins
15
2023
636
0.870
Why?
Folic Acid Antagonists
4
2005
9
0.860
Why?
Angiogenesis Inhibitors
8
2018
221
0.850
Why?
Prognosis
52
2019
3787
0.820
Why?
Gene Dosage
10
2018
143
0.800
Why?
Male
205
2024
63146
0.780
Why?
Neutropenia
12
2022
135
0.770
Why?
Immunohistochemistry
25
2020
1694
0.770
Why?
Female
198
2024
68162
0.760
Why?
Survival Rate
23
2020
1884
0.740
Why?
Antigens, Neoplasm
14
2009
308
0.730
Why?
Gene Amplification
9
2019
102
0.720
Why?
Enzyme Inhibitors
10
2016
827
0.720
Why?
Receptor Protein-Tyrosine Kinases
10
2022
234
0.710
Why?
Smoking
20
2019
1501
0.700
Why?
Chemotherapy, Adjuvant
10
2015
380
0.680
Why?
Retirement
1
2020
27
0.660
Why?
Medical Oncology
6
2003
273
0.650
Why?
Brain Neoplasms
18
2023
1137
0.640
Why?
Pathologists
1
2019
15
0.640
Why?
Treatment Outcome
42
2023
10239
0.620
Why?
Tubulin Modulators
1
2018
9
0.590
Why?
Aged, 80 and over
36
2024
7050
0.590
Why?
Furans
1
2018
22
0.590
Why?
Sputum
11
2019
309
0.580
Why?
Ketones
1
2018
47
0.570
Why?
Acrylamides
3
2024
58
0.570
Why?
T-Lymphocytes
54
2020
1905
0.560
Why?
Randomized Controlled Trials as Topic
20
2018
1366
0.560
Why?
Global Health
3
2024
317
0.540
Why?
Karnofsky Performance Status
1
2016
39
0.540
Why?
Aurora Kinase B
1
2016
8
0.540
Why?
Thymidylate Synthase
4
2005
12
0.530
Why?
Cell Division
23
2007
800
0.530
Why?
Sulindac
5
2007
17
0.520
Why?
Proto-Oncogene Proteins c-met
6
2020
75
0.520
Why?
Interferon Type I
12
1995
138
0.510
Why?
Pneumonectomy
3
2015
150
0.510
Why?
Dose-Response Relationship, Drug
22
2016
1968
0.500
Why?
Awards and Prizes
1
2016
65
0.500
Why?
Neoplasm Proteins
5
2009
428
0.500
Why?
Organophosphates
1
2016
114
0.500
Why?
Gene Rearrangement
8
2018
151
0.490
Why?
Cell Cycle
12
2015
581
0.490
Why?
Adult
123
2024
35361
0.490
Why?
Cell Line, Tumor
18
2019
3100
0.470
Why?
Precancerous Conditions
7
2018
164
0.470
Why?
Chemoprevention
5
2019
88
0.450
Why?
Genomics
3
2020
715
0.450
Why?
Genes, erbB-2
8
2017
28
0.440
Why?
Esophagitis
3
2012
66
0.430
Why?
Disease Progression
15
2024
2603
0.430
Why?
Neoplasms
10
2010
2426
0.430
Why?
Genes, erbB-1
6
2015
17
0.420
Why?
Cadherins
6
2012
186
0.420
Why?
Cell Transformation, Neoplastic
6
2004
322
0.420
Why?
Aniline Compounds
2
2024
95
0.410
Why?
AMP-Activated Protein Kinases
1
2014
187
0.400
Why?
Mass Screening
6
2020
1121
0.400
Why?
Neoplasm Metastasis
16
2024
608
0.390
Why?
Ribonucleotide Reductases
4
2004
22
0.390
Why?
Mice, Nude
18
2017
680
0.390
Why?
Neoplasm Recurrence, Local
10
2024
952
0.390
Why?
Disease-Free Survival
11
2018
657
0.380
Why?
Drug Screening Assays, Antitumor
10
2009
195
0.380
Why?
Melanoma
5
2022
735
0.370
Why?
Neuropeptides
6
1998
70
0.370
Why?
Drug Administration Schedule
18
2011
760
0.370
Why?
Early Detection of Cancer
7
2024
349
0.370
Why?
Pyridines
6
2013
472
0.370
Why?
TOR Serine-Threonine Kinases
1
2014
379
0.360
Why?
Proto-Oncogene Proteins p21(ras)
9
2019
264
0.360
Why?
Bronchi
7
2018
253
0.360
Why?
National Cancer Institute (U.S.)
1
2010
43
0.350
Why?
Esophagus
1
2012
253
0.340
Why?
Signal Transduction
18
2017
4857
0.340
Why?
Time Factors
33
2018
6568
0.340
Why?
Animals
67
2019
34628
0.340
Why?
Head and Neck Neoplasms
4
2009
527
0.330
Why?
Genotype
2
2014
1834
0.330
Why?
Fever
5
2001
301
0.330
Why?
Cell Proliferation
9
2018
2337
0.320
Why?
Drug Delivery Systems
2
2010
328
0.320
Why?
Predictive Value of Tests
12
2014
1967
0.320
Why?
Drug Monitoring
1
2010
193
0.320
Why?
Phosphorylation
6
2016
1685
0.320
Why?
Biomedical Research
5
2024
654
0.310
Why?
B7-H1 Antigen
2
2022
174
0.310
Why?
Receptors, Vascular Endothelial Growth Factor
3
2009
109
0.310
Why?
Calcium
6
2002
1173
0.310
Why?
Salvage Therapy
2
2007
136
0.300
Why?
Topotecan
3
2024
12
0.300
Why?
Drug Therapy, Combination
28
2002
1020
0.300
Why?
Xenograft Model Antitumor Assays
8
2019
797
0.300
Why?
Pyrazoles
5
2013
403
0.300
Why?
Lymphoma, Non-Hodgkin
6
2001
78
0.290
Why?
Meta-Analysis as Topic
6
2017
163
0.290
Why?
Cancer Vaccines
1
2009
164
0.280
Why?
Flow Cytometry
14
2006
1146
0.280
Why?
Mesothelioma
3
2004
37
0.280
Why?
Neoplasms, Experimental
4
2002
168
0.280
Why?
Biomarkers
4
2023
3874
0.280
Why?
Radiation-Sensitizing Agents
2
1997
40
0.270
Why?
Leukemia
16
2018
228
0.270
Why?
Receptors, KIR
2
2018
96
0.270
Why?
Camptothecin
5
2017
106
0.270
Why?
Oligopeptides
4
2005
256
0.270
Why?
Protease Inhibitors
2
2004
104
0.260
Why?
ras Proteins
7
2014
150
0.260
Why?
Gene Expression Profiling
9
2016
1694
0.260
Why?
Oncogene Proteins, Fusion
3
2018
195
0.260
Why?
Phosphatidylinositol 3-Kinases
4
2023
359
0.250
Why?
Interferons
7
1995
187
0.250
Why?
Mice
32
2019
16543
0.250
Why?
Bradykinin Receptor Antagonists
2
2002
3
0.250
Why?
Lung
14
2023
3925
0.250
Why?
Thrombocytopenia
8
2001
187
0.250
Why?
Carcinoma in Situ
4
2019
45
0.250
Why?
Proto-Oncogene Proteins B-raf
5
2015
210
0.250
Why?
Recombinant Proteins
14
1998
1304
0.240
Why?
Apoptosis
9
2018
2481
0.240
Why?
Topoisomerase I Inhibitors
3
2024
17
0.240
Why?
Antigens, Surface
10
1988
149
0.240
Why?
Cyclooxygenase Inhibitors
2
2002
80
0.240
Why?
Genes, ras
5
2015
97
0.240
Why?
Breast Neoplasms
9
2018
2112
0.230
Why?
Tankyrases
2
2016
13
0.230
Why?
Indium Radioisotopes
5
1991
13
0.230
Why?
Asymptomatic Infections
1
2024
23
0.230
Why?
Radiotherapy Dosage
13
2007
249
0.230
Why?
Neovascularization, Pathologic
7
2015
293
0.230
Why?
Boronic Acids
1
2004
37
0.230
Why?
Committee Membership
1
2003
2
0.220
Why?
Leukemia, Lymphoid
7
1987
27
0.220
Why?
Transplantation, Heterologous
9
2006
190
0.220
Why?
Volatile Organic Compounds
3
2013
54
0.220
Why?
Organophosphorus Compounds
1
2004
76
0.220
Why?
Organizational Objectives
1
2003
73
0.220
Why?
Liver Neoplasms
7
2015
637
0.210
Why?
United States
22
2020
13975
0.210
Why?
Pyrazines
1
2004
88
0.210
Why?
Retrospective Studies
19
2024
14546
0.210
Why?
Anticarcinogenic Agents
1
2004
76
0.210
Why?
Oncogene Addiction
1
2023
5
0.210
Why?
Tumor Microenvironment
3
2023
588
0.210
Why?
HTLV-I Infections
2
1996
22
0.210
Why?
Delivery of Health Care
1
2010
896
0.210
Why?
Follow-Up Studies
18
2019
4917
0.210
Why?
Neoplasm Transplantation
11
2004
254
0.210
Why?
Receptor, ErbB-3
3
2009
45
0.200
Why?
Bronchoscopy
10
2019
215
0.200
Why?
Doxorubicin
22
2002
319
0.200
Why?
Cluster Analysis
4
2016
479
0.200
Why?
Penicillins
22
1969
58
0.200
Why?
Drug Synergism
6
2016
354
0.200
Why?
Airway Obstruction
2
2003
157
0.200
Why?
Organoplatinum Compounds
3
2006
40
0.200
Why?
Iodine Radioisotopes
5
1992
142
0.200
Why?
Anti-Bacterial Agents
23
2001
1701
0.200
Why?
Growth Substances
4
2000
155
0.200
Why?
Biopsy
12
2023
1093
0.200
Why?
Carcinoma, Bronchogenic
10
1984
19
0.190
Why?
Alkyl and Aryl Transferases
1
2002
55
0.190
Why?
Roxithromycin
1
2001
1
0.190
Why?
Carcinoma, Transitional Cell
1
2022
60
0.190
Why?
Iloprost
2
2012
46
0.190
Why?
DNA, Neoplasm
8
2013
162
0.190
Why?
Societies
1
2001
37
0.190
Why?
Research Design
7
2008
1038
0.190
Why?
Neprilysin
2
1998
48
0.180
Why?
Biological Products
2
2023
202
0.180
Why?
Quality of Life
5
2022
2706
0.180
Why?
Biomarkers, Pharmacological
2
2019
27
0.180
Why?
Diarrhea
1
2022
179
0.180
Why?
Cell Line
24
2000
2759
0.180
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2014
136
0.180
Why?
Cell Cycle Checkpoints
2
2018
95
0.180
Why?
Pleural Neoplasms
2
2016
23
0.180
Why?
Artificial Intelligence
1
2023
233
0.180
Why?
Prospective Studies
15
2023
7060
0.180
Why?
Antibiotic Prophylaxis
1
2001
104
0.180
Why?
Smoking Prevention
1
2001
163
0.170
Why?
Programmed Cell Death 1 Receptor
2
2022
225
0.170
Why?
DNA Copy Number Variations
2
2018
172
0.170
Why?
Societies, Medical
2
2003
760
0.170
Why?
Ki-67 Antigen
4
2015
109
0.170
Why?
Age Factors
7
2016
3133
0.170
Why?
Adenocarcinoma, Bronchiolo-Alveolar
4
2012
19
0.170
Why?
Oncogenes
4
2016
111
0.170
Why?
Patient Participation
1
2003
402
0.170
Why?
GTP Phosphohydrolases
3
2015
76
0.170
Why?
Carcinoma, Large Cell
4
2012
16
0.160
Why?
Urinary Bladder Neoplasms
1
2022
224
0.160
Why?
Vaping
1
2020
57
0.160
Why?
Epidermal Growth Factor
4
2013
170
0.160
Why?
Lymph Nodes
17
1991
458
0.160
Why?
Histone Deacetylase Inhibitors
3
2012
206
0.160
Why?
Kaplan-Meier Estimate
6
2016
861
0.160
Why?
Aminoquinolines
1
2019
21
0.160
Why?
Antibodies, Viral
12
2024
598
0.160
Why?
Neuroendocrine Tumors
1
2020
100
0.160
Why?
Electronic Nicotine Delivery Systems
1
2020
91
0.150
Why?
Friends
1
2019
51
0.150
Why?
Practice Guidelines as Topic
3
2019
1523
0.150
Why?
Trastuzumab
4
2002
97
0.150
Why?
Structure-Activity Relationship
6
2018
539
0.150
Why?
Homeodomain Proteins
3
2010
480
0.150
Why?
Gene Expression
6
2008
1476
0.150
Why?
DNA Methylation
3
2018
600
0.150
Why?
Radiotherapy, Adjuvant
3
2004
211
0.150
Why?
Wasting Syndrome
1
1998
11
0.150
Why?
Genetic Predisposition to Disease
3
2011
2270
0.150
Why?
Leukemia-Lymphoma, Adult T-Cell
2
1996
13
0.150
Why?
History, 21st Century
1
2019
182
0.150
Why?
Receptor, IGF Type 1
2
2010
63
0.150
Why?
Clinical Trials, Phase II as Topic
3
2004
72
0.150
Why?
Caspase 3
2
2018
241
0.150
Why?
Interferon-alpha
4
1995
191
0.150
Why?
Immunoenzyme Techniques
5
2014
210
0.150
Why?
Tumor Escape
1
2018
38
0.150
Why?
Proto-Oncogenes
2
2014
29
0.150
Why?
Forecasting
4
2003
363
0.150
Why?
Young Adult
10
2020
12286
0.140
Why?
Smoking Cessation
3
2019
409
0.140
Why?
Lung Injury
1
2020
214
0.140
Why?
Cranial Irradiation
2
1995
68
0.140
Why?
CpG Islands
1
2018
151
0.140
Why?
Genetic Association Studies
2
2017
356
0.140
Why?
Folic Acid
4
2002
182
0.140
Why?
Lung Diseases
6
2015
755
0.140
Why?
Vitamin B 12
3
2002
120
0.140
Why?
Mutagenesis, Insertional
1
2017
66
0.140
Why?
Multiple Myeloma
5
1997
120
0.140
Why?
Bone Marrow
10
1992
262
0.140
Why?
Clinical Protocols
1
2019
255
0.140
Why?
Cyclophosphamide
19
2001
232
0.140
Why?
Cetuximab
4
2008
93
0.140
Why?
Drug Evaluation
15
1992
79
0.140
Why?
Receptors, KIR2DL3
1
2016
9
0.140
Why?
Receptors, KIR2DL4
1
2016
4
0.140
Why?
Proportional Hazards Models
6
2016
1221
0.140
Why?
Palliative Care
6
2003
712
0.140
Why?
HLA Antigens
4
1988
236
0.140
Why?
Receptors, KIR2DL1
1
2016
18
0.140
Why?
Receptors, KIR3DL1
1
2016
17
0.140
Why?
Patients
1
2018
167
0.140
Why?
Tumor Suppressor Protein p53
2
2017
508
0.140
Why?
Interleukin-2
3
1995
427
0.130
Why?
Polyploidy
1
2016
18
0.130
Why?
DNA Mutational Analysis
6
2017
391
0.130
Why?
Genes, myc
1
2016
48
0.130
Why?
RNA, Messenger
7
2014
2700
0.130
Why?
Chemoradiotherapy
1
2018
207
0.130
Why?
Pleural Effusion, Malignant
1
2016
8
0.130
Why?
Patient Selection
7
2008
671
0.130
Why?
Granulocyte Colony-Stimulating Factor
4
2001
72
0.130
Why?
Translocation, Genetic
1
2016
97
0.130
Why?
Bone Neoplasms
4
2015
227
0.130
Why?
Lymphoma, AIDS-Related
1
1996
14
0.130
Why?
Computational Biology
2
2018
587
0.130
Why?
Genetic Therapy
4
2015
292
0.130
Why?
Clinical Trials, Phase III as Topic
3
2016
91
0.130
Why?
Empathy
2
2009
172
0.130
Why?
Human T-lymphotropic virus 1
1
1996
28
0.130
Why?
Dimerization
3
2002
189
0.130
Why?
Molecular Biology
1
2016
54
0.130
Why?
Cohort Studies
9
2019
5394
0.120
Why?
Radiosurgery
2
2014
316
0.120
Why?
Membrane Proteins
3
2015
1100
0.120
Why?
Peritoneal Neoplasms
1
2016
83
0.120
Why?
Nerve Tissue Proteins
1
1999
568
0.120
Why?
Disease Models, Animal
5
2016
3994
0.120
Why?
Tumor Burden
1
2016
284
0.120
Why?
Ifosfamide
4
2008
33
0.120
Why?
Remission Induction
7
2019
269
0.120
Why?
Sex Factors
6
2015
1947
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2016
203
0.120
Why?
Patient-Specific Modeling
1
2014
39
0.120
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
149
0.120
Why?
Up-Regulation
3
2002
848
0.120
Why?
Amino Acid Sequence
6
1999
2047
0.120
Why?
HIV
1
1996
223
0.120
Why?
Prevalence
4
2023
2540
0.120
Why?
Biosensing Techniques
2
2013
115
0.110
Why?
Administration, Oral
5
2012
783
0.110
Why?
Adrenal Gland Neoplasms
1
2015
84
0.110
Why?
Bronchopulmonary Dysplasia
1
2019
383
0.110
Why?
Correction of Hearing Impairment
1
2014
15
0.110
Why?
Tomography, Spiral Computed
1
2013
27
0.110
Why?
Attitude to Computers
1
2014
27
0.110
Why?
Transcription Factors
3
2010
1634
0.110
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2014
50
0.110
Why?
Lymph Node Excision
1
2015
166
0.110
Why?
Persons With Hearing Impairments
1
2014
23
0.110
Why?
Interferon-gamma
3
1995
759
0.110
Why?
PUVA Therapy
3
1990
6
0.110
Why?
Genetic Testing
2
2011
424
0.110
Why?
Multiplex Polymerase Chain Reaction
1
2014
51
0.110
Why?
Activities of Daily Living
1
2016
382
0.110
Why?
Inhibitory Concentration 50
3
2013
83
0.110
Why?
Proto-Oncogene Proteins c-akt
5
2015
418
0.100
Why?
Physicians
2
2019
846
0.100
Why?
Deltaretrovirus Infections
3
1988
6
0.100
Why?
Retroviridae
9
1983
96
0.100
Why?
Wnt Proteins
2
2012
127
0.100
Why?
Sequence Analysis, DNA
2
2014
778
0.100
Why?
Hearing Aids
1
2014
74
0.100
Why?
Hypogonadism
1
2013
82
0.100
Why?
Hyperplasia
2
2011
171
0.100
Why?
DNA
6
1983
1406
0.100
Why?
Loss of Heterozygosity
2
2002
44
0.100
Why?
Radioimmunotherapy
1
1992
14
0.100
Why?
Software
1
2017
611
0.100
Why?
Neurosecretory Systems
2
2017
31
0.100
Why?
Polymerase Chain Reaction
3
2006
1045
0.100
Why?
Genetic Variation
1
2017
935
0.100
Why?
Risk Assessment
5
2010
3286
0.100
Why?
Risk Factors
9
2019
9792
0.090
Why?
Androgens
1
2013
173
0.090
Why?
Prostatic Neoplasms
5
2018
995
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2014
957
0.090
Why?
Meningeal Neoplasms
4
1986
88
0.090
Why?
Benzamides
1
2012
191
0.090
Why?
Molecular Sequence Data
6
1999
2842
0.090
Why?
Histones
1
2016
584
0.090
Why?
Clinical Trials, Phase I as Topic
2
2002
50
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
55
0.090
Why?
Deltaretrovirus
6
1986
12
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
3
2015
81
0.090
Why?
MAP Kinase Kinase 1
3
2015
76
0.090
Why?
Antibiotics, Antitubercular
11
1961
37
0.090
Why?
Cervical Vertebrae
2
2002
130
0.090
Why?
Antibody Formation
2
2022
284
0.090
Why?
Gold
1
2011
116
0.090
Why?
Cognition
2
2009
1093
0.090
Why?
Zinc Finger E-box-Binding Homeobox 1
2
2010
24
0.090
Why?
Hearing Loss
1
2014
208
0.090
Why?
Molecular Structure
2
2005
469
0.090
Why?
Isoenzymes
2
2004
303
0.090
Why?
Pulmonary Surgical Procedures
1
2010
8
0.090
Why?
Radionuclide Imaging
13
1991
126
0.090
Why?
Transcriptome
1
2016
871
0.090
Why?
Mucins
1
1990
71
0.090
Why?
Dermatologic Agents
11
1961
66
0.080
Why?
Stomach Neoplasms
3
1982
97
0.080
Why?
Tuberculosis
19
1970
271
0.080
Why?
Indium
5
1987
9
0.080
Why?
Radiography
9
2002
863
0.080
Why?
Placebos
3
2019
203
0.080
Why?
Random Allocation
7
2017
351
0.080
Why?
Neoplasm Invasiveness
3
2015
479
0.080
Why?
Expressed Emotion
1
2009
18
0.080
Why?
Tumor Virus Infections
3
1984
46
0.080
Why?
Lymphoma, B-Cell
1
2010
102
0.080
Why?
Tocopherols
1
2009
22
0.080
Why?
Isotretinoin
1
2009
23
0.080
Why?
Testosterone
1
2013
382
0.080
Why?
Antibodies, Neoplasm
4
2001
35
0.080
Why?
Vasodilator Agents
1
2011
325
0.080
Why?
Catheter Ablation
1
2012
324
0.080
Why?
Central Nervous System Diseases
2
1983
68
0.080
Why?
Blotting, Western
6
2014
1188
0.080
Why?
Staphylococcal Infections
7
1981
385
0.080
Why?
Kanamycin
6
1970
8
0.080
Why?
Pulmonary Disease, Chronic Obstructive
2
2007
985
0.080
Why?
Wounds, Nonpenetrating
2
2002
283
0.080
Why?
Spinal Cord Neoplasms
4
1986
39
0.080
Why?
Fluorenes
1
2009
39
0.080
Why?
Mitogen-Activated Protein Kinases
2
2002
311
0.080
Why?
MicroRNAs
2
2012
668
0.080
Why?
Receptors, Fibroblast Growth Factor
1
2008
65
0.080
Why?
Rats
6
2005
5236
0.080
Why?
Podophyllotoxin
3
2003
7
0.080
Why?
Aneuploidy
5
2010
92
0.080
Why?
Cell Survival
5
2013
1082
0.080
Why?
Reproducibility of Results
4
2023
3042
0.080
Why?
Vincristine
13
1989
109
0.080
Why?
Amides
1
2009
91
0.070
Why?
Rats, Nude
4
2003
28
0.070
Why?
Multigene Family
2
2006
197
0.070
Why?
Lymphatic Metastasis
6
2020
312
0.070
Why?
Mice, Inbred BALB C
4
2004
1230
0.070
Why?
Social Perception
1
2009
103
0.070
Why?
National Institutes of Health (U.S.)
4
1996
122
0.070
Why?
Antisocial Personality Disorder
1
2009
162
0.070
Why?
Sample Size
1
2008
117
0.070
Why?
Polymorphism, Genetic
1
2011
641
0.070
Why?
Kinetics
8
1991
1619
0.070
Why?
Multivariate Analysis
5
2016
1504
0.070
Why?
Nanoparticles
1
2011
358
0.070
Why?
Chromosome Aberrations
6
1993
148
0.070
Why?
Models, Statistical
1
1991
626
0.070
Why?
Bombesin
3
1994
12
0.070
Why?
Patient Acceptance of Health Care
1
2014
764
0.070
Why?
Inflammation
1
2018
2694
0.070
Why?
Drug Evaluation, Preclinical
2
2002
173
0.070
Why?
Immunoglobulins
2
1985
158
0.070
Why?
Fibroblast Growth Factors
1
2008
171
0.070
Why?
Exons
2
2019
330
0.070
Why?
Epithelial Cells
4
2007
1059
0.070
Why?
Receptors, Growth Factor
2
1997
55
0.070
Why?
Incidence
3
2018
2634
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2002
339
0.070
Why?
Epitopes
3
1986
466
0.070
Why?
Psychological Tests
1
2007
133
0.070
Why?
Congresses as Topic
3
2020
217
0.070
Why?
Radioisotopes
4
1987
31
0.070
Why?
Databases, Genetic
2
2018
226
0.070
Why?
Bevacizumab
1
2007
130
0.070
Why?
Mesoderm
1
2007
139
0.070
Why?
Cytokines
4
1997
1995
0.060
Why?
Radioimmunoassay
3
1986
169
0.060
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1987
63
0.060
Why?
Tegafur
1
2005
3
0.060
Why?
Immunologic Factors
3
1996
227
0.060
Why?
Platinum Compounds
1
2005
10
0.060
Why?
Uracil
1
2005
29
0.060
Why?
Teniposide
2
2003
3
0.060
Why?
Aging
2
2014
1767
0.060
Why?
Receptors, Cell Surface
2
2001
379
0.060
Why?
Area Under Curve
2
2005
285
0.060
Why?
In Situ Nick-End Labeling
2
2003
125
0.060
Why?
Vascular Endothelial Growth Factor A
1
2008
528
0.060
Why?
beta 2-Microglobulin
1
1985
49
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2014
1264
0.060
Why?
Resting Phase, Cell Cycle
1
2005
15
0.060
Why?
Adolescent
10
2020
20197
0.060
Why?
PTEN Phosphohydrolase
1
2006
148
0.060
Why?
Anti-Infective Agents
4
2001
246
0.060
Why?
Drug Resistance
5
2006
166
0.060
Why?
G1 Phase
1
2005
70
0.060
Why?
Matrix Metalloproteinase Inhibitors
2
2005
15
0.060
Why?
Affect
1
2007
287
0.060
Why?
Radiation, Ionizing
1
2005
75
0.060
Why?
Binding Sites, Antibody
1
1984
42
0.060
Why?
Regression Analysis
3
2003
987
0.060
Why?
Injections, Subcutaneous
3
2002
145
0.060
Why?
Selenium
2
2004
37
0.060
Why?
Drug Therapy
5
1983
77
0.060
Why?
Animal Welfare
1
2004
13
0.060
Why?
Bortezomib
1
2004
44
0.060
Why?
Data Collection
1
2007
652
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2018
484
0.060
Why?
Radiotherapy
6
1994
186
0.060
Why?
Biological Therapy
1
2004
30
0.060
Why?
Retroviridae Infections
4
1985
46
0.060
Why?
JNK Mitogen-Activated Protein Kinases
2
2002
159
0.060
Why?
Karyotyping
6
1996
107
0.060
Why?
Retinoids
1
2004
33
0.060
Why?
Planning Techniques
1
2003
15
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
73
0.060
Why?
Decision Making, Organizational
1
2003
26
0.060
Why?
Lymphoma, Large B-Cell, Diffuse
3
1976
113
0.060
Why?
Nucleocapsid
1
2023
18
0.060
Why?
Immunologic Tests
1
2023
19
0.060
Why?
Surveys and Questionnaires
4
2014
5355
0.050
Why?
Biotechnology
1
2004
42
0.050
Why?
Lymphocytes
1
1985
369
0.050
Why?
Vitamin E
1
2004
118
0.050
Why?
Vaccination
2
2022
1350
0.050
Why?
Necrosis
1
2004
234
0.050
Why?
Transfection
1
2006
904
0.050
Why?
Immunotoxins
2
1995
45
0.050
Why?
Nervous System Neoplasms
1
1983
2
0.050
Why?
Methotrexate
11
1986
248
0.050
Why?
Diagnostic Imaging
2
2009
327
0.050
Why?
Cyclooxygenase 2
1
2004
172
0.050
Why?
Radiation Tolerance
1
2004
97
0.050
Why?
Meninges
4
1982
37
0.050
Why?
Pilot Projects
3
2012
1545
0.050
Why?
Proteomics
3
2007
985
0.050
Why?
Methylmalonic Acid
1
2002
62
0.050
Why?
Killer Cells, Natural
2
1988
422
0.050
Why?
Fruit
1
2003
131
0.050
Why?
Epithelial-Mesenchymal Transition
2
2017
190
0.050
Why?
Enzyme Activation
2
2002
811
0.050
Why?
Farnesyltranstransferase
1
2002
35
0.050
Why?
Pandemics
2
2022
1516
0.050
Why?
Vegetables
1
2003
146
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Automation
1
2002
81
0.050
Why?
Streptozocin
3
1983
16
0.050
Why?
Autoradiography
3
1981
76
0.050
Why?
Injections, Intralesional
1
2002
34
0.050
Why?
Parents
2
2009
1301
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2007
772
0.050
Why?
Infusion Pumps
1
2002
31
0.050
Why?
Skin
7
1987
737
0.050
Why?
Tetrazolium Salts
1
2002
19
0.050
Why?
Injections, Intraperitoneal
1
2002
106
0.050
Why?
Homocysteine
1
2002
150
0.050
Why?
SEER Program
1
2003
208
0.050
Why?
Hypercalcemia
4
1986
21
0.050
Why?
Peptides
3
2001
902
0.050
Why?
Proteome
1
2006
423
0.050
Why?
Antigen-Antibody Complex
4
1986
84
0.050
Why?
Mechlorethamine
3
1994
63
0.050
Why?
Metalloendopeptidases
2
2002
58
0.050
Why?
Testis
1
2002
143
0.050
Why?
Mediastinal Neoplasms
1
2002
39
0.050
Why?
Indoles
1
2024
378
0.050
Why?
Infusions, Intravenous
3
2004
395
0.050
Why?
Multicenter Studies as Topic
1
2003
287
0.050
Why?
Ciprofloxacin
1
2001
30
0.050
Why?
Thiazoles
1
2002
115
0.050
Why?
Dietary Supplements
2
2004
533
0.050
Why?
Confidence Intervals
2
2017
318
0.050
Why?
Leukopenia
5
1995
27
0.050
Why?
Pedigree
3
2000
491
0.050
Why?
Pyrimidines
1
2024
444
0.050
Why?
Kinins
1
2001
3
0.050
Why?
Endpoint Determination
1
2001
76
0.050
Why?
Fluorescence
1
2001
159
0.050
Why?
Double-Blind Method
2
2019
1858
0.050
Why?
HIV Infections
1
1996
2696
0.050
Why?
Neoplastic Cells, Circulating
2
1984
67
0.050
Why?
Receptors, Antigen, T-Cell
1
1985
699
0.050
Why?
Leukemia, Plasma Cell
1
1980
4
0.040
Why?
Paraproteinemias
1
1980
4
0.040
Why?
Hypergammaglobulinemia
1
1980
9
0.040
Why?
Central Nervous System
1
2023
254
0.040
Why?
Plasmacytoma
1
1980
16
0.040
Why?
Lymphoproliferative Disorders
3
1988
53
0.040
Why?
Cell Count
3
1996
316
0.040
Why?
Sensitivity and Specificity
3
2015
1840
0.040
Why?
Endothelium, Vascular
2
2004
917
0.040
Why?
Microscopy, Fluorescence
1
2002
404
0.040
Why?
Microtubules
1
2003
252
0.040
Why?
Receptors, Interleukin-2
2
1995
65
0.040
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2020
50
0.040
Why?
Telomerase
1
2002
228
0.040
Why?
Antioxidants
1
2004
557
0.040
Why?
Ploidies
4
2003
17
0.040
Why?
Receptors, Virus
1
2020
81
0.040
Why?
Histocompatibility Antigens Class II
2
2020
359
0.040
Why?
Genes, Tumor Suppressor
1
2000
86
0.040
Why?
Lipoxygenase Inhibitors
1
1999
37
0.040
Why?
Observer Variation
1
2020
321
0.040
Why?
Algorithms
3
2015
1626
0.040
Why?
ELAV Proteins
1
1999
14
0.040
Why?
Gene Transfer Techniques
2
1998
159
0.040
Why?
Carcinoembryonic Antigen
1
1979
42
0.040
Why?
Costs and Cost Analysis
1
2000
211
0.040
Why?
Sepsis
3
1981
561
0.040
Why?
Stomach Diseases
1
1979
20
0.040
Why?
Streptomycin
8
1954
16
0.040
Why?
Feasibility Studies
2
2000
859
0.040
Why?
Electrons
4
1989
78
0.040
Why?
Light
1
2001
355
0.040
Why?
Stomach
1
1979
109
0.040
Why?
Antibodies
3
1990
392
0.040
Why?
gamma Catenin
1
2018
14
0.040
Why?
Protein Kinase C
1
2000
258
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Spinal Cord Injuries
1
2002
190
0.040
Why?
Smokers
1
2019
135
0.040
Why?
Administration, Topical
2
1994
148
0.040
Why?
History, 20th Century
2
1996
294
0.040
Why?
HIV Wasting Syndrome
1
1998
4
0.040
Why?
Teaching
1
2020
209
0.040
Why?
Case-Control Studies
3
2012
3334
0.040
Why?
Bronchial Diseases
1
2018
39
0.040
Why?
Carcinoma
4
2001
214
0.040
Why?
Tissue Distribution
5
1990
295
0.040
Why?
Postoperative Care
1
2000
246
0.040
Why?
Colorectal Neoplasms
2
2013
730
0.040
Why?
Hematologic Diseases
3
1995
61
0.040
Why?
RNA, Small Interfering
2
2012
575
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Models, Molecular
2
2018
1477
0.040
Why?
Skin Diseases
2
1979
143
0.040
Why?
Organoids
1
2019
100
0.040
Why?
Pneumonia
6
1968
612
0.040
Why?
Retinoblastoma Binding Proteins
1
2017
4
0.040
Why?
Genes, p53
1
1998
69
0.040
Why?
DNA Topoisomerases, Type I
1
2017
16
0.040
Why?
Type C Phospholipases
1
1998
72
0.040
Why?
Communicable Diseases
4
1964
141
0.040
Why?
Preoperative Care
1
2000
343
0.040
Why?
North America
1
1998
289
0.040
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
181
0.040
Why?
Web Browser
1
2017
12
0.030
Why?
Drug Resistance, Multiple
1
1997
21
0.030
Why?
Receptors, Notch
1
2017
85
0.030
Why?
Demecolcine
1
1976
2
0.030
Why?
Endocarditis, Subacute Bacterial
3
1964
3
0.030
Why?
Mice, SCID
1
2017
340
0.030
Why?
Bronchial Neoplasms
1
1996
14
0.030
Why?
Risk
5
2001
866
0.030
Why?
Platinum
1
2016
43
0.030
Why?
B-Lymphocytes
5
1986
813
0.030
Why?
Maximum Tolerated Dose
2
2007
195
0.030
Why?
T-Lymphocytes, Helper-Inducer
2
1996
137
0.030
Why?
Tuberculosis, Ocular
5
1954
8
0.030
Why?
Registries
1
2024
1916
0.030
Why?
Longitudinal Studies
1
2003
2668
0.030
Why?
Ubiquitin-Protein Ligases
1
2017
155
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
170
0.030
Why?
Mitogens
4
1998
58
0.030
Why?
Carcinogenesis
1
2017
200
0.030
Why?
Endocarditis
3
1964
36
0.030
Why?
Receptors, Cytokine
1
1996
35
0.030
Why?
Drug Stability
1
1996
150
0.030
Why?
RNA-Binding Proteins
1
1999
382
0.030
Why?
Mice, Inbred NOD
1
2017
579
0.030
Why?
Diet
1
2003
1205
0.030
Why?
Premedication
1
1995
40
0.030
Why?
Comorbidity
2
2016
1542
0.030
Why?
Analgesics, Non-Narcotic
1
1997
123
0.030
Why?
Colonic Neoplasms
1
2018
234
0.030
Why?
Growth Inhibitors
2
2002
43
0.030
Why?
Rabbits
10
2005
757
0.030
Why?
Meningitis
4
1974
81
0.030
Why?
Hematopoiesis
1
1976
184
0.030
Why?
Cross-Linking Reagents
1
1996
200
0.030
Why?
Pathology, Molecular
1
2015
25
0.030
Why?
Ovarian Neoplasms
1
2000
474
0.030
Why?
GTP-Binding Proteins
1
1996
156
0.030
Why?
Drug Tolerance
1
1995
82
0.030
Why?
Interferon-beta
1
1995
88
0.030
Why?
Military Medicine
1
1996
61
0.030
Why?
Severity of Illness Index
1
2003
2767
0.030
Why?
HLA-A Antigens
2
1985
53
0.030
Why?
Diphtheria Toxin
1
1995
56
0.030
Why?
HLA-C Antigens
2
1985
35
0.030
Why?
Biological Specimen Banks
1
1996
101
0.030
Why?
Guinea Pigs
3
2005
158
0.030
Why?
Bone Marrow Transplantation
2
1986
267
0.030
Why?
Wnt Signaling Pathway
1
2016
164
0.030
Why?
Photopheresis
1
1994
9
0.030
Why?
HLA-B Antigens
2
1985
62
0.030
Why?
Whole-Body Irradiation
3
1991
76
0.030
Why?
Antigens, Viral
4
1984
181
0.030
Why?
Colorado
2
2014
4443
0.030
Why?
Glioblastoma
1
2018
311
0.030
Why?
Mitomycin
2
1992
32
0.030
Why?
Molecular Diagnostic Techniques
1
2015
93
0.030
Why?
Cholecystokinin
1
1994
14
0.030
Why?
Proteins
1
2000
945
0.030
Why?
Cell Cycle Proteins
1
2018
576
0.030
Why?
Methoxsalen
1
1994
4
0.030
Why?
Substance P
1
1994
44
0.030
Why?
Ultraviolet Therapy
1
1994
18
0.030
Why?
gamma-Globulins
2
1965
18
0.030
Why?
Research
2
1994
413
0.030
Why?
Histiocytoma, Benign Fibrous
1
1994
8
0.030
Why?
Contraindications
1
1994
90
0.030
Why?
Glioma
1
2018
347
0.030
Why?
Texas
1
2014
227
0.030
Why?
Pyridazines
1
2014
48
0.030
Why?
Odds Ratio
1
2016
1019
0.030
Why?
Serum Albumin
2
2013
145
0.030
Why?
Micrococcus
3
1958
4
0.030
Why?
Tumor Stem Cell Assay
3
1992
32
0.030
Why?
Staphylococcus
3
1970
74
0.030
Why?
Fibroblasts
1
1998
946
0.030
Why?
Safety
1
1995
325
0.030
Why?
DNA-Binding Proteins
1
2000
1423
0.030
Why?
Endoscopy
1
2015
268
0.030
Why?
DNA Fingerprinting
1
2013
25
0.030
Why?
Muscle Denervation
1
1973
12
0.030
Why?
Sex Hormone-Binding Globulin
1
2013
53
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
326
0.030
Why?
Ileum
2
2005
113
0.030
Why?
Urinary Tract Infections
3
1970
144
0.030
Why?
In Vitro Techniques
5
2002
1061
0.030
Why?
Maintenance Chemotherapy
1
2013
22
0.030
Why?
Imidazoles
1
2014
224
0.030
Why?
Consensus
1
2016
644
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Radiation Dosage
2
1992
159
0.030
Why?
Magnetic Resonance Imaging
2
2023
3348
0.030
Why?
Treatment Failure
1
1994
345
0.030
Why?
Auditory Perception
1
2014
109
0.030
Why?
DNA Primers
2
2009
522
0.030
Why?
NAD(P)H Dehydrogenase (Quinone)
1
1992
31
0.030
Why?
Neuromuscular Junction
1
1973
56
0.030
Why?
Chromosome Banding
4
1996
21
0.030
Why?
Luteinizing Hormone
1
2013
177
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
126
0.020
Why?
International Cooperation
2
2003
172
0.020
Why?
Breath Tests
1
2012
91
0.020
Why?
Mitomycins
2
1984
4
0.020
Why?
Hearing
1
2014
134
0.020
Why?
Pyrimidinones
1
2013
101
0.020
Why?
Recombinant Fusion Proteins
1
1995
640
0.020
Why?
Adrenocorticotropic Hormone
4
1954
131
0.020
Why?
Cooperative Behavior
1
2015
427
0.020
Why?
Bone Marrow Examination
1
1992
6
0.020
Why?
Ionomycin
1
1992
24
0.020
Why?
Species Specificity
2
2005
566
0.020
Why?
Ricin
1
1991
8
0.020
Why?
Probability
3
2009
313
0.020
Why?
Equipment Design
1
2014
522
0.020
Why?
Nanostructures
1
2013
98
0.020
Why?
Immunization, Passive
2
2001
82
0.020
Why?
Chromosome Deletion
2
1982
104
0.020
Why?
Properdin
2
1962
8
0.020
Why?
Benzimidazoles
1
2013
158
0.020
Why?
Radiometry
1
1992
48
0.020
Why?
Follicle Stimulating Hormone
1
2013
238
0.020
Why?
Gene Frequency
1
2013
503
0.020
Why?
Liver
5
1987
1832
0.020
Why?
Fatigue
2
2005
319
0.020
Why?
Ambulatory Care
1
1995
509
0.020
Why?
Logistic Models
1
2016
1963
0.020
Why?
Immunosorbent Techniques
1
1991
18
0.020
Why?
Laboratories
2
1963
102
0.020
Why?
Pyridones
1
2013
158
0.020
Why?
Tuberculosis, Pulmonary
4
1959
135
0.020
Why?
Waldenstrom Macroglobulinemia
2
1982
11
0.020
Why?
Acquired Immunodeficiency Syndrome
2
1990
226
0.020
Why?
Lomustine
7
1986
14
0.020
Why?
Iceland
1
2011
10
0.020
Why?
Drug Hypersensitivity
2
1970
92
0.020
Why?
Japan
2
2009
100
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Vimentin
1
2011
50
0.020
Why?
Evidence-Based Medicine
1
2015
729
0.020
Why?
Spain
1
2011
36
0.020
Why?
Perception
1
2014
336
0.020
Why?
Antibodies, Anti-Idiotypic
1
1991
56
0.020
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
822
0.020
Why?
Adsorption
1
1991
138
0.020
Why?
Netherlands
1
2011
77
0.020
Why?
Mutation, Missense
1
2013
319
0.020
Why?
Zinc Finger E-box Binding Homeobox 2
1
2010
5
0.020
Why?
Residence Characteristics
1
2014
326
0.020
Why?
Cross-Sectional Studies
2
2015
5032
0.020
Why?
Motor Neurons
1
1973
236
0.020
Why?
Photochemotherapy
2
1980
28
0.020
Why?
Tissue Array Analysis
1
2010
55
0.020
Why?
Megakaryocytes
3
1980
32
0.020
Why?
Databases, Factual
1
1996
1289
0.020
Why?
Diagnosis, Differential
2
2002
1435
0.020
Why?
Serine Endopeptidases
1
2010
113
0.020
Why?
Sequence Homology, Nucleic Acid
1
1990
150
0.020
Why?
Thyroid Neoplasms
1
1994
308
0.020
Why?
Radiotherapy, High-Energy
2
1980
13
0.020
Why?
Base Sequence
2
2009
2157
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
2
1988
20
0.020
Why?
Clone Cells
3
1985
257
0.020
Why?
Nervous System Diseases
3
1985
260
0.020
Why?
Carrier Proteins
1
1994
728
0.020
Why?
Nicotinic Acids
3
1954
6
0.020
Why?
Hemagglutination Tests
2
1964
7
0.020
Why?
Niacin
3
1954
19
0.020
Why?
Mitosis
3
1981
177
0.020
Why?
Down-Regulation
1
1992
637
0.020
Why?
Calcitriol
2
1986
56
0.020
Why?
Bacterial Infections
2
2001
236
0.020
Why?
Deafness
1
1970
79
0.020
Why?
Diethylstilbestrol
2
1986
9
0.020
Why?
Isoniazid
3
1954
59
0.020
Why?
Personality Inventory
1
2009
138
0.020
Why?
Infusions, Parenteral
2
1986
39
0.020
Why?
Immunoprecipitation
1
2009
159
0.020
Why?
Insulin-Like Growth Factor I
1
1991
308
0.020
Why?
Referral and Consultation
1
2014
727
0.020
Why?
Ovary
1
1990
212
0.020
Why?
Histocytochemistry
3
1983
78
0.020
Why?
Thoracic Surgery
1
2010
133
0.020
Why?
Tuberculosis, Meningeal
4
1964
6
0.020
Why?
Herpes Simplex
2
1987
94
0.020
Why?
Statistics, Nonparametric
1
2009
424
0.020
Why?
Tomography, X-Ray Computed
3
2002
2530
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2011
420
0.020
Why?
Fluorescent Antibody Technique
2
1987
392
0.020
Why?
In Situ Hybridization
1
2008
295
0.020
Why?
Pulmonary Fibrosis
2
1986
381
0.020
Why?
Tetracycline
2
1958
12
0.020
Why?
Bone Marrow Cells
3
1980
291
0.020
Why?
New South Wales
1
2007
14
0.020
Why?
Rosette Formation
2
1987
16
0.020
Why?
Queensland
1
2007
40
0.020
Why?
Ampicillin
2
1965
14
0.020
Why?
Immunophenotyping
2
2001
310
0.020
Why?
Eye
3
1954
104
0.020
Why?
Protein Synthesis Inhibitors
2
1958
41
0.020
Why?
Actuarial Analysis
1
1987
25
0.020
Why?
Body Fluids
2
1964
61
0.020
Why?
Remission, Spontaneous
4
1980
38
0.020
Why?
Fluorouracil
2
1998
198
0.020
Why?
Repressor Proteins
1
2010
400
0.020
Why?
Pneumonia, Pneumococcal
2
1960
41
0.020
Why?
Procarbazine
5
1986
8
0.020
Why?
Receptors, Progesterone
1
1989
342
0.020
Why?
Dyspnea
2
1986
236
0.020
Why?
Hydrocortisone
2
1981
300
0.020
Why?
Principal Component Analysis
1
2007
185
0.020
Why?
Genome, Human
1
2009
393
0.020
Why?
Calcitonin
1
1986
24
0.020
Why?
Nucleotidases
2
1985
7
0.020
Why?
Colony-Forming Units Assay
1
1986
89
0.020
Why?
Genome
1
2009
276
0.020
Why?
California
1
2008
402
0.020
Why?
Reference Values
1
2008
791
0.020
Why?
Bacillus
2
1957
16
0.020
Why?
Phosphates
2
1958
168
0.020
Why?
Sulfadiazine
1
1966
4
0.020
Why?
DNA Repair
1
2008
208
0.020
Why?
Nocardia Infections
1
1966
8
0.020
Why?
Gram-Positive Bacteria
2
1957
45
0.020
Why?
Antigen-Antibody Reactions
1
1966
51
0.020
Why?
Radioisotope Dilution Technique
1
1986
13
0.020
Why?
Farmer's Lung
1
1965
3
0.020
Why?
Immunoglobulin Idiotypes
1
1986
27
0.020
Why?
Dose-Response Relationship, Immunologic
1
1986
82
0.020
Why?
Insecta
2
1957
66
0.020
Why?
Vomiting
3
2001
128
0.020
Why?
Erythromycin
2
1958
25
0.020
Why?
Mice, Inbred A
1
2005
49
0.020
Why?
Child
4
2009
20824
0.020
Why?
Deoxyribonucleosides
1
1985
2
0.020
Why?
Urea
1
1966
75
0.020
Why?
Databases, Nucleic Acid
1
2005
34
0.020
Why?
Dose-Response Relationship, Radiation
1
1986
131
0.020
Why?
Indicators and Reagents
1
1986
108
0.020
Why?
Freezing
1
1986
86
0.020
Why?
Peritonitis
1
1966
81
0.020
Why?
Child, Preschool
3
2007
10457
0.020
Why?
DNA Damage
1
2008
377
0.020
Why?
Mathematics
1
1986
103
0.020
Why?
Cell Movement
2
1981
932
0.020
Why?
Blood
1
1985
99
0.020
Why?
HLA-B35 Antigen
1
1985
3
0.020
Why?
HLA-B8 Antigen
1
1985
14
0.020
Why?
Enzymes
1
2005
65
0.020
Why?
Phenylalanine
1
2005
60
0.020
Why?
Analysis of Variance
1
2008
1283
0.020
Why?
Mycoses
1
1966
70
0.020
Why?
Bleomycin
2
1978
241
0.020
Why?
Carcinogens
1
2005
109
0.020
Why?
Nucleic Acid Hybridization
1
1985
191
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
1985
87
0.020
Why?
Genes, MHC Class II
1
1985
72
0.020
Why?
Myeloma Proteins
1
1984
14
0.020
Why?
Lymphokines
1
1985
126
0.020
Why?
Haemophilus
1
1965
7
0.010
Why?
Melphalan
1
1984
30
0.010
Why?
Exanthema
1
2005
76
0.010
Why?
Endocytosis
1
1986
162
0.010
Why?
Histocompatibility Testing
1
1985
122
0.010
Why?
Carmustine
1
1984
50
0.010
Why?
Viral Proteins
3
1981
329
0.010
Why?
Tyrosine
1
2005
219
0.010
Why?
Monocytes
2
1985
553
0.010
Why?
Syndrome
3
1984
342
0.010
Why?
Endocarditis, Bacterial
1
1965
42
0.010
Why?
Cross Reactions
1
1984
129
0.010
Why?
Nausea
2
2001
104
0.010
Why?
Psychology, Child
1
2004
37
0.010
Why?
Hemagglutination
1
1964
8
0.010
Why?
Bronchopneumonia
1
1964
5
0.010
Why?
DNA, Recombinant
1
1984
46
0.010
Why?
Acute Disease
2
1984
978
0.010
Why?
Genome-Wide Association Study
1
2011
1334
0.010
Why?
DNA Replication
1
2005
225
0.010
Why?
Acetaminophen
1
1987
255
0.010
Why?
Nephritis, Interstitial
1
1984
13
0.010
Why?
Expectorants
1
1964
24
0.010
Why?
Nephrosis, Lipoid
1
1984
10
0.010
Why?
Hypersensitivity, Delayed
1
1983
28
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2005
289
0.010
Why?
Densitometry
2
1980
32
0.010
Why?
Chromosomes, Human, Pair 7
1
2003
15
0.010
Why?
Cell Transformation, Viral
2
1984
28
0.010
Why?
Chromosomes
2
1982
100
0.010
Why?
Prednisone
1
1984
241
0.010
Why?
Paraneoplastic Syndromes
1
1983
12
0.010
Why?
Muscles
3
1982
322
0.010
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2003
17
0.010
Why?
Toxicology
1
1964
42
0.010
Why?
Virus Diseases
1
1966
207
0.010
Why?
Growth Hormone
2
1954
96
0.010
Why?
Biopsy, Needle
2
1982
191
0.010
Why?
Vital Capacity
1
2004
285
0.010
Why?
Cloxacillin
1
1963
1
0.010
Why?
Transfer Factor
1
1983
1
0.010
Why?
Vitamins
1
2004
171
0.010
Why?
Tuberculosis, Miliary
3
1964
5
0.010
Why?
Furunculosis
1
1962
1
0.010
Why?
Sex Ratio
1
1983
14
0.010
Why?
Razoxane
1
1982
1
0.010
Why?
Receptors, Bradykinin
1
2002
5
0.010
Why?
Leukapheresis
1
1983
21
0.010
Why?
Thymosin
2
1980
5
0.010
Why?
Allergy and Immunology
1
1964
60
0.010
Why?
Antilymphocyte Serum
1
1983
63
0.010
Why?
Poly(ADP-ribose) Polymerases
1
2003
89
0.010
Why?
Cell Membrane
2
2002
728
0.010
Why?
Drainage
1
1964
162
0.010
Why?
Pneumococcal Infections
2
1956
110
0.010
Why?
Mycobacterium tuberculosis
2
1957
312
0.010
Why?
T-Lymphocytes, Cytotoxic
1
1983
166
0.010
Why?
Nucleoside Deaminases
1
1982
2
0.010
Why?
Pentosyltransferases
1
1982
6
0.010
Why?
Purine-Nucleoside Phosphorylase
1
1982
5
0.010
Why?
Autopsy
1
1983
89
0.010
Why?
Lymphocyte Activation
3
1983
1091
0.010
Why?
Streptococcal Infections
1
1965
145
0.010
Why?
Cells, Cultured
7
1985
4048
0.010
Why?
Adenosine Deaminase
1
1982
26
0.010
Why?
Forced Expiratory Volume
1
2004
509
0.010
Why?
Bacteriophages
2
1961
93
0.010
Why?
Keratins
1
2003
176
0.010
Why?
Cysteine
1
1964
190
0.010
Why?
Immunity, Cellular
2
1984
266
0.010
Why?
Gastrointestinal Tract
1
2004
182
0.010
Why?
Agglutinins
1
1962
2
0.010
Why?
Umbilical Cord
1
2002
84
0.010
Why?
Clinical Enzyme Tests
1
1982
11
0.010
Why?
Aggression
1
2004
192
0.010
Why?
Phosphopyruvate Hydratase
1
1982
27
0.010
Why?
Leukemia, Erythroblastic, Acute
1
1982
7
0.010
Why?
Receptors, Fc
1
1982
49
0.010
Why?
Abdominal Neoplasms
1
1982
32
0.010
Why?
Manipulation, Spinal
1
2002
7
0.010
Why?
Caspases
1
2003
248
0.010
Why?
Rectal Diseases
1
1981
19
0.010
Why?
Complement System Proteins
2
1962
307
0.010
Why?
Bone Resorption
1
1982
77
0.010
Why?
False Positive Reactions
1
2002
115
0.010
Why?
Sulfonamides
2
1955
494
0.010
Why?
Herpesvirus 4, Human
2
1980
153
0.010
Why?
Receptors, Immunologic
1
1983
213
0.010
Why?
Immune System
1
1983
175
0.010
Why?
Oculomotor Muscles
2
1951
39
0.010
Why?
Promoter Regions, Genetic
1
2006
1194
0.010
Why?
CD52 Antigen
1
2001
4
0.010
Why?
Spinal Fractures
1
2002
81
0.010
Why?
Alemtuzumab
1
2001
15
0.010
Why?
Zymosan
1
1961
65
0.010
Why?
Carcinoma, Hepatocellular
1
1983
267
0.010
Why?
Glasgow Coma Scale
1
2002
170
0.010
Why?
Phenotype
4
1984
3059
0.010
Why?
APUD Cells
1
1980
1
0.010
Why?
Furocoumarins
1
1980
8
0.010
Why?
Single-Blind Method
1
2001
273
0.010
Why?
Neoplasms, Hormone-Dependent
1
2000
38
0.010
Why?
Polysaccharides
1
1961
84
0.010
Why?
Cell Line, Transformed
1
2000
140
0.010
Why?
Amyloidosis
1
1980
39
0.010
Why?
Hospitals, Chronic Disease
2
1958
2
0.010
Why?
Immunoglobulin Heavy Chains
1
1980
80
0.010
Why?
Intestinal Neoplasms
1
1980
28
0.010
Why?
Biological Assay
1
2001
117
0.010
Why?
Neoplasm, Residual
1
2001
115
0.010
Why?
Chromosomes, Human
1
1980
41
0.010
Why?
Cytological Techniques
1
1980
25
0.010
Why?
Piperazines
1
1982
326
0.010
Why?
Leukocytes
2
1984
301
0.010
Why?
Quality Assurance, Health Care
1
2002
319
0.010
Why?
Health Resources
1
2001
121
0.010
Why?
Hypersensitivity
1
1964
277
0.010
Why?
Anemia
1
2001
155
0.010
Why?
Antiviral Agents
1
1966
708
0.010
Why?
Soft Tissue Neoplasms
1
1981
111
0.010
Why?
Bacteremia
1
1962
190
0.010
Why?
Disease Management
1
1964
594
0.010
Why?
Brain
3
1985
2592
0.010
Why?
Thymus Hormones
1
1979
1
0.010
Why?
Influenza, Human
1
1985
603
0.010
Why?
Carcinogens, Environmental
1
1979
7
0.010
Why?
Range of Motion, Articular
1
2002
386
0.010
Why?
Stomach Ulcer
1
1979
10
0.010
Why?
Gastroscopy
1
1979
18
0.010
Why?
Joint Instability
1
2002
181
0.010
Why?
Duodenal Ulcer
1
1979
11
0.010
Why?
Spinal Cord
1
1982
360
0.010
Why?
Osteoporosis
1
1982
233
0.010
Why?
History, 19th Century
1
1979
56
0.010
Why?
Glycoproteins
1
2001
340
0.010
Why?
Semustine
1
1978
1
0.010
Why?
Neuroblastoma
1
1980
152
0.010
Why?
Hybridomas
2
1994
234
0.010
Why?
Demeclocycline
1
1978
3
0.010
Why?
Spinal Cord Compression
1
1978
19
0.010
Why?
Blood Platelets
2
1984
369
0.010
Why?
Cost-Benefit Analysis
1
2002
615
0.010
Why?
Protein Biosynthesis
1
2000
409
0.010
Why?
Antigens, CD
1
2001
479
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1998
28
0.010
Why?
Phospholipase C beta
1
1998
27
0.010
Why?
Chloramphenicol
1
1958
9
0.010
Why?
Levamisole
1
1998
19
0.010
Why?
Vasopressins
1
1978
64
0.010
Why?
Gastritis
1
1979
98
0.010
Why?
Radiation Injuries
1
1979
139
0.010
Why?
Antibody Specificity
3
1983
185
0.010
Why?
Practice Patterns, Physicians'
1
2006
1281
0.010
Why?
Estradiol
1
1981
494
0.010
Why?
Cell Separation
3
1986
311
0.010
Why?
Hormones, Ectopic
1
1977
2
0.010
Why?
T-Lymphocytes, Regulatory
1
1980
377
0.010
Why?
Occupational Diseases
1
1979
142
0.010
Why?
Amantadine
2
1968
6
0.010
Why?
Thoracotomy
1
1997
75
0.010
Why?
GPI-Linked Proteins
1
1997
67
0.010
Why?
Vinca Alkaloids
1
1976
4
0.010
Why?
Genetic Markers
1
1998
335
0.010
Why?
Capsules
1
1957
37
0.010
Why?
Staining and Labeling
1
1977
142
0.010
Why?
Penicillin V
1
1956
3
0.010
Why?
Cephalosporins
2
1968
39
0.010
Why?
Immunoglobulin G
2
1994
834
0.010
Why?
Cycloserine
1
1956
5
0.010
Why?
Gentamicins
2
1968
51
0.010
Why?
Pregnancy
1
1989
6247
0.010
Why?
Colchicine
1
1976
26
0.010
Why?
Novobiocin
1
1956
5
0.010
Why?
Gallium Radioisotopes
1
1975
14
0.010
Why?
Maryland
1
1996
43
0.010
Why?
Computer Communication Networks
1
1996
32
0.010
Why?
Sulfisoxazole
1
1955
1
0.010
Why?
Arthritis
1
1957
113
0.010
Why?
Herpes Zoster
1
1980
349
0.010
Why?
Glycopeptides
1
1996
44
0.010
Why?
Laparoscopy
1
1980
452
0.010
Why?
Cerebrospinal Fluid
1
1976
94
0.010
Why?
Cyclic AMP
1
1996
230
0.010
Why?
Bronchoalveolar Lavage Fluid
1
1997
642
0.010
Why?
Folate Receptors, GPI-Anchored
1
1994
5
0.010
Why?
Streptococcus pneumoniae
1
1956
157
0.010
Why?
Portal System
1
1953
12
0.010
Why?
Phlebitis
1
1953
11
0.010
Why?
Leucomycins
1
1953
1
0.010
Why?
Dogs
2
1987
372
0.010
Why?
Respiratory Function Tests
2
1986
596
0.010
Why?
Veins
1
1953
60
0.010
Why?
Heart Neoplasms
1
1994
50
0.010
Why?
Isomerism
1
1953
48
0.010
Why?
Thyroid Gland
1
1994
94
0.010
Why?
Gallamine Triethiodide
1
1973
1
0.010
Why?
Edrophonium
1
1973
2
0.010
Why?
Organ Specificity
1
1994
296
0.010
Why?
Pulmonary Alveoli
1
1996
403
0.010
Why?
Disease
1
1953
95
0.010
Why?
Sciatic Nerve
1
1973
59
0.010
Why?
Human Growth Hormone
1
1953
44
0.010
Why?
Cats
1
1973
211
0.010
Why?
Chromosomes, Human, 1-3
2
1982
2
0.010
Why?
RNA, Neoplasm
1
1992
89
0.010
Why?
Meningitis, Pneumococcal
1
1952
7
0.010
Why?
Killer Cells, Lymphokine-Activated
1
1992
12
0.010
Why?
Cytotoxicity, Immunologic
2
1983
214
0.010
Why?
Appendicitis
1
1953
133
0.010
Why?
Electric Stimulation
1
1973
266
0.010
Why?
Recurrence
3
1980
1013
0.010
Why?
Models, Biological
1
1979
1702
0.010
Why?
Hormones
1
1952
139
0.010
Why?
Evaluation Studies as Topic
2
1982
175
0.010
Why?
Erythrocytes
1
1976
667
0.010
Why?
Perfusion
1
1992
191
0.010
Why?
Vestibulocochlear Nerve
1
1970
7
0.010
Why?
Klebsiella
1
1970
4
0.010
Why?
Blood Cell Count
2
1981
54
0.010
Why?
Organ of Corti
1
1970
14
0.010
Why?
Synaptic Transmission
1
1973
258
0.010
Why?
Chlortetracycline
1
1950
4
0.010
Why?
Insulin
1
1981
2311
0.010
Why?
Drug Resistance, Microbial
1
1970
67
0.010
Why?
Injections
1
1991
174
0.010
Why?
Enterobacteriaceae Infections
1
1970
37
0.010
Why?
Culture Media
2
1981
168
0.010
Why?
Kidney
2
1984
1330
0.010
Why?
Microscopy, Electron
2
1982
417
0.010
Why?
Paralysis
1
1970
71
0.010
Why?
Promegestone
1
1989
33
0.010
Why?
Muscle Contraction
1
1973
426
0.010
Why?
Action Potentials
1
1973
463
0.010
Why?
Formaldehyde
1
1989
57
0.010
Why?
Chickenpox
1
1950
100
0.010
Why?
Neuromuscular Diseases
1
1970
106
0.000
Why?
DNA Nucleotidyltransferases
1
1968
11
0.000
Why?
Thrombocythemia, Essential
1
1988
7
0.000
Why?
Polymyxins
1
1968
9
0.000
Why?
Immunoglobulin Isotypes
1
1987
35
0.000
Why?
Hepatic Insufficiency
1
1947
4
0.000
Why?
Whole-Body Counting
1
1987
6
0.000
Why?
Lysosomes
1
1968
139
0.000
Why?
Propidium
1
1986
8
0.000
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1988
110
0.000
Why?
Medroxyprogesterone
1
1986
10
0.000
Why?
Kidney Diseases
1
1970
366
0.000
Why?
Medroxyprogesterone Acetate
1
1986
35
0.000
Why?
Infant
1
1980
8994
0.000
Why?
Coloring Agents
1
1986
78
0.000
Why?
Orchiectomy
1
1986
64
0.000
Why?
Cephaloridine
1
1966
1
0.000
Why?
Immunodiffusion
1
1965
15
0.000
Why?
Immunoglobulin M
1
1987
268
0.000
Why?
Sulfanilamides
2
1955
2
0.000
Why?
Polymers
1
1989
475
0.000
Why?
Spleen
1
1987
518
0.000
Why?
Immunization
1
1987
416
0.000
Why?
Tuberculosis, Renal
1
1964
1
0.000
Why?
Pathology
1
1964
15
0.000
Why?
Death, Sudden
1
1964
25
0.000
Why?
Canada
1
1965
355
0.000
Why?
Memory Disorders
1
1985
156
0.000
Why?
Purines
1
1985
170
0.000
Why?
Molecular Weight
1
1984
332
0.000
Why?
Polyethylene Glycols
1
1989
598
0.000
Why?
Blood Cells
1
1984
39
0.000
Why?
Urticaria
1
1984
42
0.000
Why?
Cell Differentiation
2
1985
1854
0.000
Why?
West Indies
1
1983
4
0.000
Why?
Leukemia, Hairy Cell
1
1983
6
0.000
Why?
Leucovorin
1
1983
69
0.000
Why?
Alabama
1
1983
37
0.000
Why?
Aspartate Aminotransferases
1
1983
86
0.000
Why?
Georgia
1
1983
79
0.000
Why?
Florida
1
1983
91
0.000
Why?
Respiratory Tract Infections
1
1968
372
0.000
Why?
Skin Tests
1
1983
126
0.000
Why?
Warfarin
1
1984
150
0.000
Why?
Osteosclerosis
1
1982
2
0.000
Why?
Anemia, Sideroblastic
1
1982
3
0.000
Why?
Pulmonary Embolism
1
1964
211
0.000
Why?
Adrenal Glands
1
1982
72
0.000
Why?
Agranulocytosis
1
1981
30
0.000
Why?
Leukocyte Count
1
1982
328
0.000
Why?
Technetium Tc 99m Pyrophosphate
1
1981
1
0.000
Why?
Technetium
1
1981
11
0.000
Why?
Viral Core Proteins
1
1981
21
0.000
Why?
Electrophysiology
1
1982
205
0.000
Why?
Creatinine
1
1983
485
0.000
Why?
Peripheral Nerves
1
1982
67
0.000
Why?
Diphosphates
1
1981
17
0.000
Why?
Transferrin
1
1981
42
0.000
Why?
Abscess
1
1981
73
0.000
Why?
Immune Sera
1
1981
88
0.000
Why?
Fluorometry
1
1980
19
0.000
Why?
Photomicrography
1
1980
7
0.000
Why?
Microscopy, Phase-Contrast
1
1980
16
0.000
Why?
Mental Disorders
1
1949
1024
0.000
Why?
DNA-Directed DNA Polymerase
1
1980
45
0.000
Why?
Substance-Related Disorders
1
1949
1019
0.000
Why?
Haplorhini
1
1980
57
0.000
Why?
Dermatitis, Exfoliative
1
1980
4
0.000
Why?
Purpura
1
1980
12
0.000
Why?
Castration
1
1980
14
0.000
Why?
Macrophage Migration-Inhibitory Factors
1
1980
10
0.000
Why?
Alopecia
1
1979
28
0.000
Why?
Receptors, Complement
1
1980
120
0.000
Why?
Cocarcinogenesis
1
1979
14
0.000
Why?
Chemical Industry
1
1979
10
0.000
Why?
Receptors, Antigen, B-Cell
1
1980
121
0.000
Why?
Methods
1
1978
63
0.000
Why?
Fiber Optic Technology
1
1978
17
0.000
Why?
Solvents
1
1979
107
0.000
Why?
Hemoglobins
1
1981
343
0.000
Why?
Pesticides
1
1979
58
0.000
Why?
Mucous Membrane
1
1978
122
0.000
Why?
Granulocytes
1
1976
79
0.000
Why?
Herpesvirus 3, Human
1
1980
398
0.000
Why?
Air Pollutants
1
1979
321
0.000
Why?
Postoperative Complications
1
1983
2494
0.000
Why?
Hospitals, University
1
1946
177
0.000
Why?
Biological Transport
1
1946
394
0.000
Why?
Minnesota
1
1964
145
0.000
Why?
Students
1
1946
576
0.000
Why?
Bunn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)